Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 7,680.00
+70.00 (0.92%)
At close: Sep 11, 2026
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 117.9 billion as of September 11, 2026. Its market cap has decreased by -12.63% in one year.
Market Cap
117.90B
Enterprise Value
371.32B
Revenue
630.89B
Ranking
n/a
PE Ratio
13.98
Stock Price
7,680.00
ChartMarket Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 117.90B, an increase of 348.35%. That is a compound annual growth rate of 4.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 117.90B | -4.48% |
| Dec 30, 2025 | 123.42B | 2.81% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ilsung Is | 150.88B |
| Samil Pharmaceutical Co.,Ltd | 150.02B |
| Hana Pharm | 149.29B |
| Ilyang Pharmaceutical Co.,Ltd | 148.24B |
| Jeil Pharmaceutical Co.,Ltd | 148.05B |
| Dongwha Pharm.Co.,Ltd | 142.47B |
| Dong Sung Bio Pharm.Co.,Ltd. | 132.66B |
| SAMSUNG PHARM. Co., LTD. | 129.60B |